In recent trading session, Matinas Biopharma Holdings Inc (AMEX:MTNB) saw 2.64 million shares changing hands at last check today with its beta currently measuring 1.65. Company’s recent per share price level of $0.62 trading at $0.06 or 12.40% at last check today assigns it a market valuation of $3.12M. That most recent trading price of MTNB’s stock is at a discount of -3367.74% from its 52-week high price of $21.50 and is indicating a premium of 19.35% from its 52-week low price of $0.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.46 million shares which gives us an average trading volume of 113.53K if we extend that period to 3-months.
Matinas Biopharma Holdings Inc (AMEX:MTNB) trade information
Upright in the green today for gaining 12.40%, in the last five days MTNB remained trading in the green while hitting it’s week-highest on Friday, 11/08/24 when the stock touched $0.62 price level, adding 18.92% to its value on the day. Matinas Biopharma Holdings Inc’s shares saw a change of -94.23% in year-to-date performance and have moved 7.20% in past 5-day. Matinas Biopharma Holdings Inc (AMEX:MTNB) showed a performance of -80.57% in past 30-days. Number of shares sold short was 80434.0 shares which calculate 2.24 days to cover the short interests.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Matinas Biopharma Holdings Inc (AMEX:MTNB)’s Major holders
Insiders are in possession of 2.53% of company’s total shares while institution are holding 28.39 percent of that, with stock having share float percentage of 29.13%. Investors also watch the number of corporate investors in a company very closely, which is 28.39% institutions for Matinas Biopharma Holdings Inc that are currently holding shares of the company. HIGHBRIDGE CAPITAL MANAGEMENT LLC is the top institutional holder at MTNB for having 10.64 million shares of worth $1.68 million. And as of 2024-06-30, it was holding 4.8971 of the company’s outstanding shares.
The second largest institutional holder is VANGUARD GROUP INC, which was holding about 9.32 million shares on 2024-06-30. The number of shares represents firm’s hold over 4.2869 of outstanding shares, having a total worth of $1.48 million.
